Abstract
Natural products play a crucial role in research into innovative antiproliferative agents. More than 60% of anticancer drugs involve compounds of natural origin. The aim of the present study was to determine the cytotoxicity effects of 11 quinoline alkaloids isolated from plants of the Rutaceae family. The MTT assay was used to identify the antiproliferative effects of the tested compounds on human adherent cancer cell lines (HeLa, A431, MCF7 and A2780). Two of these alkaloids, kokusaginine and skimmianine, were found to inhibit the proliferation of cancer cells and to induce a cell cycle arrest in a concentration-dependent manner in HeLa cells, as evidenced by flow cytometry. A noncancerous human fibroblast cell line (MRC-5) was used to test the selectivity of kokusaginine and skimmianine. Fluorescent microscopy after Hoechst 33258 + propidium iodide double staining revealed concentration-dependent nuclear condensation and disturbed cell membrane integrity. The apoptotic potentials of kokusaginine and skimmianine were proved by assaying caspase-3. The presented results demonstrate that kokusaginine and skimmianine can be recommended as appropriate starting structures for the design and synthesis of further quinoline analogs with improved efficacy.
Keywords: Quinoline alkaloids, kokusaginine, skimmianine, cancer cells, apoptosis.
Current Signal Transduction Therapy
Title:Investigation of the Antiproliferative Action of the Quinoline Alkaloids Kokusaginine and Skimmianine on Human Cell Lines
Volume: 8 Issue: 2
Author(s): Judit Molnar, Imre Ocsovszki, Laszlo Puskas, Tannaz Ghane, Judit Hohmann and István Zupko
Affiliation:
Keywords: Quinoline alkaloids, kokusaginine, skimmianine, cancer cells, apoptosis.
Abstract: Natural products play a crucial role in research into innovative antiproliferative agents. More than 60% of anticancer drugs involve compounds of natural origin. The aim of the present study was to determine the cytotoxicity effects of 11 quinoline alkaloids isolated from plants of the Rutaceae family. The MTT assay was used to identify the antiproliferative effects of the tested compounds on human adherent cancer cell lines (HeLa, A431, MCF7 and A2780). Two of these alkaloids, kokusaginine and skimmianine, were found to inhibit the proliferation of cancer cells and to induce a cell cycle arrest in a concentration-dependent manner in HeLa cells, as evidenced by flow cytometry. A noncancerous human fibroblast cell line (MRC-5) was used to test the selectivity of kokusaginine and skimmianine. Fluorescent microscopy after Hoechst 33258 + propidium iodide double staining revealed concentration-dependent nuclear condensation and disturbed cell membrane integrity. The apoptotic potentials of kokusaginine and skimmianine were proved by assaying caspase-3. The presented results demonstrate that kokusaginine and skimmianine can be recommended as appropriate starting structures for the design and synthesis of further quinoline analogs with improved efficacy.
Export Options
About this article
Cite this article as:
Molnar Judit, Ocsovszki Imre, Puskas Laszlo, Ghane Tannaz, Hohmann Judit and Zupko István, Investigation of the Antiproliferative Action of the Quinoline Alkaloids Kokusaginine and Skimmianine on Human Cell Lines, Current Signal Transduction Therapy 2013; 8 (2) . https://dx.doi.org/10.2174/15743624113086660006
DOI https://dx.doi.org/10.2174/15743624113086660006 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry A Review of Fertility Preservation with Radical Vaginal Trachelectomy and Laparoscopic Pelvic Lymphadenectomy in the Treatment of Early Cervical Cancer
Current Women`s Health Reviews New Improved Drug Delivery Technologies for Pentacyclic Triterpenes: A Review
Protein & Peptide Letters Curcumin Sensitizes Cancers Towards TRAIL-induced Apoptosis via Extrinsic and Intrinsic Apoptotic Pathways
Current Drug Targets Comparison of the Mean Minimum Dose of Bolus Oxytocin for Proper Uterine Contraction during Cesarean Section
Current Clinical Pharmacology Targeting mTOR Pathways in Human Malignancies
Current Pharmaceutical Design Potential MicroRNA Targets for Cancer Chemotherapy
Current Medicinal Chemistry Control of Neuropathic Pain by Immune Cells and Opioids
CNS & Neurological Disorders - Drug Targets Reactive Oxygen and Nitrogen Species in Carcinogenesis: Implications of Oxidative Stress on the Progression and Development of Several Cancer Types
Mini-Reviews in Medicinal Chemistry Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
Current Pharmaceutical Design Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?
Current Pharmaceutical Design Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Oral HPV Infection: Current Strategies for Prevention and Therapy
Current Pharmaceutical Design PET with Non-Standard Nuclides
Current Topics in Medicinal Chemistry IP6 & Inositol in Cancer Prevention and Therapy
Current Cancer Therapy Reviews Synthesis, Biological Evaluation, Molecular Docking Study and Acute Oral Toxicity Study of Coupled Imidazole-Pyrimidine Derivatives
Letters in Drug Design & Discovery A New Role for Zn(II) Aminopeptidases: Antigenic Peptide Generation and Destruction
Current Pharmaceutical Design Electrochemical Cell-based Biosensors for Biomedical Applications
Current Topics in Medicinal Chemistry Carvacrol Exhibits Chemopreventive Potential against Cervical Cancer Cells via Caspase-Dependent Apoptosis and Abrogation of Cell Cycle Progression
Anti-Cancer Agents in Medicinal Chemistry